The risk of antimalarials in patients with renal failure.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 18057166.
- Also identified by PMC identifier 2750932.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We present here a patient with end stage renal failure who received two weeks antimalarial prophylaxis at full dose leading to life threatening toxicity with severe acute megaloblastic anaemia, symptomatic pancytopenia and exfoliative dermatitis. Prompt recognition and treatment can rapidly reverse these fatal effects but more importantly, education of patients before travel is imperative in preventing such events.
Medical subject headings
- Anemia, Megaloblastic
- Antimalarials
- Dermatitis, Exfoliative
- Kidney Failure, Chronic
- Malaria
- Pancytopenia